Effect of Fish Oil Supplementation on Hyperlipidemia during Childhood Acute Lymphoblastic Leukemia Treatment – A Pilot Study

2020 ◽  
pp. 1-5
Author(s):  
Renate D. Laumann ◽  
Turid Iversen ◽  
Pernille R. Mogensen ◽  
Lotte Lauritzen ◽  
Christian Mølgaard ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Pilot Study ◽  
Fish Oil ◽  
Lymphoblastic Leukemia ◽  
Childhood Acute Lymphoblastic Leukemia ◽  
Leukemia Treatment ◽  
Fish Oil Supplementation

Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment

2018 ◽  
Vol 19 (18) ◽  
pp. 1403-1412 ◽  
Author(s):  
Ángela Gutierrez-Camino ◽  
Maitane Umerez ◽  
Elixabet Lopez-Lopez ◽  
Borja Santos-Zorrozua ◽  
Idoia Martin-Guerrero ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Lymphoblastic Leukemia ◽  
Childhood Acute Lymphoblastic Leukemia ◽  
Leukemia Treatment

#722 Childhood acute lymphoblastic leukemia treatment in a less developed country-Istanbul experience

1998 ◽  
Vol 20 (4) ◽  
pp. 418
Author(s):  
L. Agaoghu ◽  
U. Ozgen ◽  
O. Devecioglu ◽  
S. Anak ◽  
N. Yalman ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Lymphoblastic Leukemia ◽  
Childhood Acute Lymphoblastic Leukemia ◽  
Developed Country ◽  
Leukemia Treatment ◽  
Less Developed Country

Late adverse effects of childhood acute lymphoblastic leukemia treatment on developing dentition

2021 ◽  
Author(s):  
Egle Immonen ◽  
Atte Nikkilä ◽  
Timo Peltomäki ◽  
Liisa Aine ◽  
Olli Lohi
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Adverse Effects ◽  
Lymphoblastic Leukemia ◽  
Childhood Acute Lymphoblastic Leukemia ◽  
Leukemia Treatment ◽  
Late Adverse Effects

Influence of Socioeconomic Status on Childhood Acute Lymphoblastic Leukemia Treatment in Indonesia

PEDIATRICS ◽  
2006 ◽  
Vol 118 (6) ◽  
pp. e1600-e1606 ◽  
Author(s):  
S. Mostert ◽  
M. N. Sitaresmi ◽  
C. M. Gundy ◽  
Sutaryo ◽  
A. J. P. Veerman
Keyword(s):  
Socioeconomic Status ◽  
Acute Lymphoblastic Leukemia ◽  
Lymphoblastic Leukemia ◽  
Childhood Acute Lymphoblastic Leukemia ◽  
Leukemia Treatment

scholarly journals Expression Profile of LncRNAs in Childhood Acute Lymphoblastic Leukemia: A Pilot Study

2020 ◽  
Vol 27 (3) ◽  
pp. 385-392
Author(s):  
Zohreh Mousavi ◽  
Saeid Ghorbian ◽  
Azim Rezamand ◽  
Leyla Roshangar ◽  
Behboud Jafari
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Pilot Study ◽  
Lymphoblastic Leukemia ◽  
Childhood Acute Lymphoblastic Leukemia ◽  
P Value ◽  
Blood Samples ◽  
Cellular Processes ◽  
Diagnosis And Prognosis ◽  
Causes Of Disease ◽  
The Relationship

Background: Childhood acute lymphoblastic leukemia (ALL) explains 26% of pediatricmalignancies and is one of the leading causes of disease-related deaths in children. A novelmolecular class of non-coding genes, long non-coding RNAs (lncRNAs) having over 200nucleotides, have been defined as regulators of different cellular processes including pluripotency,oncogenesis, and transcription. It has been demonstrated that lncRNA transcription profilescan distinguish pre B-cell subtype of ALL accurately and act as early diagnostic and prognosticbiomarkers. Hence, the aim of this pilot study was the prior evaluation of expression profileof several lncRNA candidates including RP11-68I18.10, RP11-624C23.1, RP11-446E9, RP11-137H2.4, and RP11-203E8 in patients with ALL. Methods: In this study, 80 blood samples were obtained from patients, definitely diagnosed bypathologists with ALL, and from healthy subjects. Total RNA was extracted from blood samples,and cDNA was synthesized. Real-time PCR was applied to determine the expression of lncRNAs.A P-value of 0.010 was considered statistically significant. Results: Our findings revealed that the expression levels of lncRNAs RP11-624C23.1, RP11-446E9, RP11-137H2.4, RP11-68I18.10, and RP11-203E8 were significantly decreased in ALLsamples compared to those of healthy samples (P<0.0001, P =0.0616, P =0.0292, P<0.0001, andP = 0.0007). Moreover, the relationship between these five lncRNA expression changes and theimmunophenotype in ALL patients was not significant. Conclusion: The dysregulation of lncRNAs in ALL samples could provide a novel and interestingpossibility for early diagnosis and prognosis, as well as mastering the treatment of ALL.

Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia treatment

Bone ◽  
2010 ◽  
Vol 46 (4) ◽  
pp. 1016-1020 ◽  
Author(s):  
Alessandro Mussa ◽  
Nicoletta Bertorello ◽  
Francesco Porta ◽  
Chiara Galletto ◽  
Mario Guido Nicolosi ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Lymphoblastic Leukemia ◽  
Childhood Acute Lymphoblastic Leukemia ◽  
Bone Ultrasound ◽  
Leukemia Treatment

scholarly journals Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A pediatric oncology group pilot study

Cancer ◽  
1993 ◽  
Vol 71 (9) ◽  
pp. 2854-2861 ◽  
Author(s):  
Stephen J. Lauer ◽  
Bruce M. Camitta ◽  
Brigid G. Leventhal ◽  
Donald H. Mahoney ◽  
Jonathan J. Shuster ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Pilot Study ◽  
High Risk ◽  
Pediatric Oncology ◽  
Lymphoblastic Leukemia ◽  
Childhood Acute Lymphoblastic Leukemia ◽  
Oncology Group ◽  
Pediatric Oncology Group

Mexican Childhood Acute Lymphoblastic Leukemia: A Pilot Study of the MDR1 and MTHFR Gene Polymorphisms and Their Associations with Clinical Outcomes

2016 ◽  
Vol 20 (10) ◽  
pp. 597-602 ◽  
Author(s):  
Arturo Ramírez-Pacheco ◽  
Selene Moreno-Guerrero ◽  
Ilse Alamillo ◽  
Aurora Medina-Sanson ◽  
Briseida Lopez ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Pilot Study ◽  
Clinical Outcomes ◽  
Gene Polymorphisms ◽  
Lymphoblastic Leukemia ◽  
Mthfr Gene ◽  
Childhood Acute Lymphoblastic Leukemia
Sign in / Sign up

Export Citation Format

Share Document